Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL8005364 | 0.97 | CA1 (0.30) | CA1CA2CA7CA13 | |
| SCHEMBL8981567 | 0.79 | — | — | |
| SCHEMBL28906871 | 0.77 | CA1 (0.35) | CA1CA2CA7CA13 | |
| SCHEMBL14569456 | 0.72 | CA1 (0.32) | CA1CA2CA7CA13 | |
| SCHEMBL28468558 | 0.72 | CA1 (0.32) | CA1CA2CA7CA13 | |
| SCHEMBL17793229 | 0.72 | CA1 (0.32) | CA1CA2CA7CA13 | |
| SCHEMBL17426904 | 0.72 | — | — | |
| SCHEMBL10398437 | 0.72 | — | — | |
| SCHEMBL28345281 | 0.72 | — | — | |
| Hydrogen Sulfide SCHEMBL3374431 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116113256-A | Precursor material of electron injection layer, preparation method and application thereof | 宁波杭州湾新材料研究院 | 2023-05-12 | — | — | CN | claimed |
| US-20240238425-A1 | HSD17B13 Inhibitors and/or Degraders | PFIZER INC. (US) | 2024-07-18 | — | — | US | disclosed |
| US-11681222-B2 | Fluorine-containing polymer, purification method, and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2023-06-20 | — | — | US | disclosed |
| CN-116113256-A | Precursor material of electron injection layer, preparation method and application thereof | 宁波杭州湾新材料研究院 | 2023-05-12 | — | — | CN | disclosed |
| US-20220137508-A9 | FLUORINE-CONTAINING POLYMER, PURIFICATION METHOD, AND RADIATION-SENSITIVE RESIN COMPOSITION | JSR CORPORATION (JP) | 2022-05-05 | — | — | US | disclosed |
| WO-2017088730-A1 | SILICONE-CONTAINING COMPOUND FOR RESISTING HEPATITIS C VIRUS INFECTION | 正大天晴药业集团股份有限公司 | 2017-06-01 | — | — | WO | disclosed |
| EP-1669421-B1 | Ink composition for a color filter, a color filter substrate manufactured using the ink composition and method of manufacturing a color filter substrate using the ink composition | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-07-18 | — | — | EP | disclosed |
| EP-1669421-A1 | Ink composition for a color filter, a color filter substrate manufactured using the ink composition and method of manufacturing a color filter substrate using the ink composition | Samsung Electronics Co., Ltd. (KR) | 2006-06-14 | — | — | EP | disclosed |
| US-6960654-B2 | Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2005-11-01 | — | — | US | disclosed |
| US-20040019198-A1 | Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide | CRICH DAVID C (US) | 2004-01-29 | — | — | US | disclosed |
| EP-0722446-A1 | DISTAMYCIN A ANALOGUES AS ANTITUMOUR OR ANTIVIRAL AGENTS | PHARMACIA & UPJOHN S.p.A. (IT) | 1996-07-24 | — | — | EP | disclosed |
| US-5512470-A | Method for inhibiting sialidase activity | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-04-30 | — | — | US | disclosed |
| WO-1996005196-A1 | DISTAMYCIN A ANALOGUES AS ANTITUMOUR OR ANTIVIRAL AGENTS | PHARMACIA S.P.A. (IT) | 1996-02-22 | — | — | WO | disclosed |
| US-5489675-A | POWERFUL ANTIVIRAL AND ANTIBACTERIAL AGENTS SPECIALLY INFLUENZA VIRUS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-02-06 | — | — | US | disclosed |
| EP-0678097-A1 | NOVEL COLON- OR ILEUM-SPECIFIC STEROID DERIVATIVES | AKTIEBOLAGET ASTRA (SE) | 1995-10-25 | — | — | EP | disclosed |
| EP-0675733-A1 | PEPTIDE-CARBOHYDRATE CONJUGATES GENERATING T-CELL IMMUNITY | Astra Aktiebolag (SE) | 1995-10-11 | — | — | EP | disclosed |
| EP-0642523-A1 | GANGLIOSIDE ANALOGS. | SYMBICOM AB (SE) | 1995-03-15 | — | — | EP | disclosed |
| WO-1994015947-A1 | NOVEL COLON- OR ILEUM-SPECIFIC STEROID DERIVATIVES | ASTRA AKTIEBOLAG (SE) | 1994-07-21 | — | — | WO | disclosed |
| WO-1993021948-A1 | PEPTIDE-CARBOHYDRATE CONJUGATES GENERATING T-CELL IMMUNITY | ASTRA AKTIEBOLAG (SE) | 1993-11-11 | — | — | WO | disclosed |
| WO-1993010134-A1 | GANGLIOSIDE ANALOGS | SYMBICOM AKTIEBOLAG (SE) | 1993-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238425-A1 | HSD17B13 Inhibitors and/or Degraders | HSD17B13, HSD17B3, HSD17B1 | CA1 3878/4885CA2 3939/4885CA7 2775/4885 |
| US-20040019198-A1 | Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide | DDOST, STT3B, STT3A | CA1 203/4885CA2 573/4885CA7 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.